Jamil Khatri, MD
Dr. Jhamil Khatri is a hematologist and oncologist at ChristianaCare in Newark, Delaware and its associated Helen F. Graham Cancer Center. He specializes in treating patients diagnosed with lung cancer and other thoracic malignancies, including malignant pleural mesothelioma. He also cares for patients with blood disorders and other cancer diagnoses.[1]
As a member of the thoracic multidisciplinary team, Dr. Khatri works collaboratively with other cancer specialists, including surgeons and radiation oncologists, as well as with supportive and palliative care professionals, primary care practitioners, genetic counselors, nutritional support, physical rehabilitation therapists, psychologists, and social services staff.
Education and Career
Dr. Khatri began his medical education in Pakistan, where he graduated from Dow Medical College. After moving to the United States, he completed an internship and residency in Internal Medicine at Cooper University Hospital in Camden, New Jersey, where he also completed a fellowship in Hematology and Oncology.[1]
Professional Memberships and Activities
Dr. Khatri is board-certified in Medical Oncology and Hematology by the American Board of Internal Medicine. He is a member of the American Society of Clinical Oncology.
Research
Dr. Khatri is actively involved in research and clinical trials at Christiana Care’s Helen F. Graham Cancer Center and Research Institute. He has authored several publications in respected medical journals, including:[2]
- Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit. Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, …>; Cancer Research Communications. 2023 Jul 1
- Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit. Scott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, Daniel H Hovelson, Melissa J Shreve, Laura E Lamb, Marc R Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William…>; Communications Medicine. 2023 Feb 7
- Consensus statement and clinical pathway for the management of colon cancer with peritoneal metastases in the state of Delaware. Jesus Esquivel, Nicholas Petrelli, James Spellman, Joseph Bennett, Suguna Chirla, Jamil Khatri, Gregory Masters>; Surgical Oncology. 2023 Dec 1
